Carfilzomib‐Induced Thrombotic Microangiopathy—Two Case Reports

ABSTRACTBackgroundThrombotic microangiopathy (TMA) is a pathological syndrome characterized by a combination of three key features: microangiopathic hemolytic anemia (MAHA), thrombocytopenia, and organ damage, primarily affecting the kidneys. There are several drugs known to have a definite or proba...

Full description

Bibliographic Details

Published in:	Cancer Reports
Main Authors:	Irene Attucci, Sofia Pilerci, Maria Messeri, Ludovica Pengue, Giulia Tomasino, Leonardo Caroti, Alessandro M. Vannucchi, Elisabetta Antonioli
Format:	Article
Language:	English
Published:	Wiley 2024-10-01
Subjects:	carfilzomib proteasome inhibitors renal impairment thrombotic microangiopathy
Online Access:	https://doi.org/10.1002/cnr2.2163